Moerlein S M, Weisman R A, Beck D, Li A P, Welch M J
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110.
Nucl Med Biol. 1993 Jan;20(1):49-56. doi: 10.1016/0969-8051(93)90135-h.
An in vitro technique for the determination of radiopharmaceutical metabolism has been developed using isolated hepatocytes. Radioiodinated N-isopropyl-p-iodoamphetamine (IMP; iofetamine, USP) was employed a model tracer in these studies because its labeled metabolites are well-characterized. Hepatocytes isolated from the rat and human produced labeled metabolites in vitro for up to 4 h in a manner similar to that reported for humans in vivo. Identical metabolites were generated by all cell types investigated, but the rate of metabolism differed (rat >> human; female > male; fresh > frozen). The utility of this methodology for the preclinical evaluation of potential radiopharmaceuticals is described.
已开发出一种利用分离的肝细胞来测定放射性药物代谢的体外技术。在这些研究中,放射性碘化的N-异丙基对碘安非他明(IMP;碘苯丙胺,美国药典)被用作模型示踪剂,因为其标记代谢物具有明确的特征。从大鼠和人类分离的肝细胞在体外产生标记代谢物长达4小时,其方式与人体体内报告的方式相似。所有研究的细胞类型都会产生相同的代谢物,但代谢速率有所不同(大鼠>>人类;雌性>雄性;新鲜>冷冻)。本文描述了该方法在潜在放射性药物临床前评估中的应用。